Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortive
FTV
|
+$1.27B |
| 2 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$706M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$439M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$413M |
| 5 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$272M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Weyerhaeuser
WY
|
+$431M |
| 2 |
Walt Disney
DIS
|
+$223M |
| 3 |
VXX
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
|
+$213M |
| 4 |
Halliburton
HAL
|
+$211M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$204M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.24% |
| 2 | Financials | 5.68% |
| 3 | Healthcare | 5.62% |
| 4 | Consumer Discretionary | 5.04% |
| 5 | Industrials | 3.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
WWE
1651
CALL
DELISTED
World Wrestling Entertainment
WWE
| $5.83M | ﹤0.01% |
60,300
-700
| -1% | -$57.9K |
|
1652
Travel + Leisure Co
TNL
$4.7B
| $5.82M | ﹤0.01% |
134,223
-144,697
| -52% | -$6.42M |
|
1653
CALL
ArcelorMittal
MT
$55.3B
| $5.82M | ﹤0.01% |
188,506
-22,600
| -11% | -$685K |
|
1654
CALL
Omega Healthcare
OHI
$14.7B
| $5.81M | ﹤0.01% |
177,200
+3,700
| +2% | +$118K |
|
1655
Zebra Technologies
ZBRA
$17.8B
| $5.81M | ﹤0.01% |
32,843
+9,515
| +41% | +$1.52M |
|
|
VVC
1656
DELISTED
Vectren Corporation
VVC
| $5.81M | ﹤0.01% |
81,212
-19,566
| -19% | -$1.4M |
|
1657
CALL
Colgate-Palmolive
CL
$74.4B
| $5.8M | ﹤0.01% |
86,600
-63,500
| -42% | -$4.23M |
|
|
SLCA
1658
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
| $5.8M | ﹤0.01% |
307,772
-58,267
| -16% | -$1.35M |
|
1659
PUT
Bath & Body Works
BBWI
$4.1B
| $5.79M | ﹤0.01% |
236,267
+96,486
| +69% | +$2.41M |
|
1660
CALL
Zions Bancorporation
ZION
$10.3B
| $5.79M | ﹤0.01% |
115,400
-369,100
| -76% | -$19.5M |
|
1661
XPO
XPO
$23.7B
| $5.78M | ﹤0.01% |
146,414
-217,494
| -60% | -$7.91M |
|
1662
CALL
Genuine Parts
GPC
$18.7B
| $5.78M | ﹤0.01% |
58,100
+12,900
| +29% | +$1.26M |
|
1663
PBF Energy
PBF
$7.31B
| $5.78M | ﹤0.01% |
115,706
-20,502
| -15% | -$974K |
|
1664
PUT
Cummins
CMI
$88.7B
| $5.77M | ﹤0.01% |
39,500
+6,500
| +20% | +$915K |
|
1665
PUT
CME Group
CME
$94.8B
| $5.75M | ﹤0.01% |
33,800
-107,500
| -76% | -$18.1M |
|
1666
Viper Energy
VNOM
$14.7B
| $5.75M | ﹤0.01% |
136,597
+126,553
| +1,260% | +$4.65M |
|
1667
Diamondrock Hospitality Co
DRH
$2.56B
| $5.74M | ﹤0.01% |
492,153
+193,127
| +65% | +$2.3M |
|
|
DNR
1668
DELISTED
Denbury Resources, Inc.
DNR
| $5.74M | ﹤0.01% |
925,706
-213,131
| -19% | -$1.06M |
|
1669
Natural Resource Partners
NRP
$1.42B
| $5.74M | ﹤0.01% |
185,000
| – | – |
|
1670
CALL
Zillow
Z
$7.56B
| $5.73M | ﹤0.01% |
129,500
-100,300
| -44% | -$5.23M |
|
|
EFOR
1671
Everforth Inc
EFOR
$1.32B
| $5.72M | ﹤0.01% |
72,458
+53,794
| +288% | +$4.65M |
|
1672
iShares MSCI Taiwan ETF
EWT
$11.1B
| $5.71M | ﹤0.01% |
151,500
+10,503
| +7% | +$389K |
|
1673
PUT
TotalEnergies
TTE
$190B
| $5.71M | ﹤0.01% |
8,127,138
-403,150
| -5% | -$276K |
|
|
AVNS
1674
DELISTED
Avanos Medical
AVNS
| $5.7M | ﹤0.01% |
83,261
+28,798
| +53% | +$1.85M |
|
1675
Teradata
TDC
$2.55B
| $5.69M | ﹤0.01% |
150,992
+44,283
| +41% | +$1.79M |
|
Similar funds
Barclays's Q3 2018 Portfolio in Review
As of Q3 2018, Barclays held 7,740 positions worth $144B, up 24% from $116B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Barclays deployed $22.2B of net new capital in Q3 2018, opening 680 new positions and adding to 3,884 existing holdings. Its largest new stake was iPath Series B S&P GSCI Crude Oil ETN: 5,000,000 shares worth $75.7M.
By sector, the portfolio is most concentrated in Technology at 8.2% of assets, up from 7.4% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Weyerhaeuser, an estimated $431M trimmed.
- Barclays's largest Q3 2018 buy was iPath Series B S&P GSCI Crude Oil ETN: 5,000,000 shares worth $75.7M.
- Barclays added most to Fortive in Q3 2018, an estimated $1.27B increase.
- Barclays's biggest Q3 2018 reduction was Weyerhaeuser, cutting an estimated $431M.
- Barclays fully exited Validus Hold Ltd in Q3 2018, selling an estimated $71M.
- Barclays's ten largest holdings make up 31% of its $144B portfolio in Q3 2018.
- Barclays opened 680 new positions and closed 408 in Q3 2018.
- Barclays's portfolio value rose 24% quarter-over-quarter to $144B.
Based on Barclays's 13F filing for Q3 2018, filed 14 Nov 2018.